Ozempic® vs Saxenda®
Once-weekly semaglutide vs once-daily liraglutide. One injection per week vs one per day — and the results differ noticeably.
BestGLP1 is not affiliated with, endorsed by, or sponsored by Novo Nordisk A/S, Eli Lilly and Company, or any other manufacturer named on this page. All trademarks are the property of their respective owners.
4.9%
Avg weight loss Ozempic*
From
$199/mo
Ozempic
June 2026
8%
Avg weight loss Saxenda*
From
$145/mo
Saxenda
June 2026
What are they?
Both are GLP-1 receptor agonists, but semaglutide (Ozempic) is weekly with stronger outcomes, while liraglutide (Saxenda) requires daily injections.
Ozempic is FDA-approved for type 2 diabetes, not for weight loss. Wegovy is the FDA-approved semaglutide formulation for chronic weight management.
Ozempic
Type 2 DiabetesFDA-approved to improve blood sugar in adults with Type 2 Diabetes. Some patients using semaglutide as part of a comprehensive medical program may also experience reduced hunger and meaningful weight reduction over time.
Maker
Novo Nordisk
Approved
2017
Format
Weekly injection
Max dose
2.0 mg
Saxenda
Weight ManagementFDA-approved for chronic weight management since 2014. Uses liraglutide — a GLP-1 receptor agonist that requires daily injection. Generic liraglutide was approved in August 2025, reducing costs.
Maker
Novo Nordisk
Approved
2014
Format
Daily injection
Max dose
3 mg
Quick comparison
How they stack up on the metrics that matter most.
| Feature | Ozempic | Saxenda |
|---|---|---|
| Active ingredient | Semaglutide | Liraglutide |
| FDA approved for | Type 2 diabetes | Weight Management |
| Avg weight loss | 4.9%† | 8%† |
| Administration | Weekly injection | Daily injection |
| Insurance | Broader | Moderate |
| Monthly Price | From $199/mo | From $145/mo |
Ozempic
Semaglutide
Saxenda
Liraglutide
Ozempic
Type 2 diabetes
Saxenda
Weight Management
Ozempic
4.9%†
Saxenda
8%†
Ozempic
Weekly injection
Saxenda
Daily injection
Ozempic
Broader
Saxenda
Moderate
Ozempic
From $199/mo
Saxenda
From $145/mo
† Average weight loss data: Ozempic — SUSTAIN-1 (semaglutide 1.0 mg, 30 weeks); Saxenda — SCALE (liraglutide 3 mg, 56 weeks).
More energy,
less weight
How you ramp up
Both medications use a gradual dose escalation to minimize side effects.
Ozempic
- 1
0.25 mg
Weeks 1–4
- 2
0.5 mg
Weeks 5–8
- 3
1.0 mg
Weeks 9+
(Maintenance)
- 4
2.0 mg
Optional max dose
Saxenda
- 1
0.6 mg
Week 1
(Daily)
- 2
1.2 mg
Week 2
(Daily)
- 3
1.8 mg
Week 3
(Daily)
- 4
2.4 mg
Week 4
(Daily)
- 5
3.0 mg
Week 5+
(Maintenance)
Start your weight‑loss
journey today
Weight loss compared
Clinical trial data showing average body weight reduction over 68 weeks.
Ozempic (1 mg)
Saxenda (3 mg)
† Average weight loss data: Ozempic — SUSTAIN-1 (semaglutide 1.0 mg, 30 weeks); Saxenda — SCALE (liraglutide 3 mg, 56 weeks).
What to expect
How they stack up on the metrics that matter most.
| Side Effect | Ozempic (1 mg) | Saxenda (3 mg) |
|---|---|---|
| Nausea | 20.3% | 39.3% |
| Diarrhea | 8.8% | 20.9% |
| Vomiting | 9.2% | 15.7% |
| Constipation | 3.1% | 19.4% |
| Headache | N/A | 13.6% |
| Fatigue | N/A | 7.5% |
Ozempic (1 mg)
20.3%
Saxenda (3 mg)
39.3%
Ozempic (1 mg)
8.8%
Saxenda (3 mg)
20.9%
Ozempic (1 mg)
9.2%
Saxenda (3 mg)
15.7%
Ozempic (1 mg)
3.1%
Saxenda (3 mg)
19.4%
Ozempic (1 mg)
N/A
Saxenda (3 mg)
13.6%
Ozempic (1 mg)
N/A
Saxenda (3 mg)
7.5%
Side effects may be more noticeable during dose escalation, but individual experiences vary and some risks can be serious. GLP-1 medications are not appropriate for everyone. Review important warnings, contraindications, and the FDA label or Medication Guide with a licensed healthcare provider before starting or switching treatment.
The bottom line
Branded GLP-1 medications can offer effective weight loss, requiring individualized risk-benefit clinical evaluation.
Two different GLP-1 options
- Ozempic is FDA-approved for type 2 diabetes, with blood-sugar control, weekly dosing convenience, and cardiovascular benefits supported by large clinical trials and long-term safety data.
- Saxenda supports steady weight loss, appetite reduction, flexible daily dosing, and long-standing clinical experience demonstrating effective, sustainable metabolic health improvements for many patients.
Providers may pay BestGLP1 a referral fee. We disclose this for FTC compliance; rankings remain editorial.
What you
need to know
On trial averages, yes — Ozempic shows roughly 15% body weight reduction versus 8.0% for Saxenda. Semaglutide’s longer half-life supports once-weekly dosing and steadier appetite suppression than daily liraglutide.
Yes. Switching from daily liraglutide to weekly semaglutide is common and your provider will typically restart you at Ozempic’s lowest dose to manage side effects. Most patients find weekly dosing easier to maintain long term.
Yes. Generic liraglutide was approved in August 2025 and has reduced Saxenda’s effective price. Availability and exact pricing vary by pharmacy and insurance — ask your provider or pharmacist for current options.
Semaglutide binds the GLP-1 receptor more potently and has a much longer half-life than liraglutide, allowing weekly dosing with stable drug levels. That sustained receptor activation is associated with greater appetite suppression and larger average weight loss in its trials than liraglutide.
Yes. Both Ozempic and Saxenda require a prescription from a licensed healthcare provider. A consultation is required to assess whether treatment is appropriate for you.
- Ozempic (semaglutide 1.0 mg). Trial: SUSTAIN 1 (388 participants, 30 weeks, adults with type 2 diabetes inadequately controlled on diet and exercise). Average weight loss: −4.9% vs −1.0% placebo. Sorli et al., Lancet Diabetes Endocrinol 2017.
- Saxenda (liraglutide 3.0 mg). Trial: SCALE Obesity and Prediabetes (3,731 participants, 56 weeks, adults with obesity/overweight without Type 2 Diabetes). Average weight loss: −8.0% vs −2.6% placebo. Pi-Sunyer et al., NEJM 2015.
BestGLP1 publishes these guides for informational and comparison purposes only. The information on this site is not medical advice, diagnosis, or treatment, and is not a substitute for guidance from a licensed healthcare professional. GLP-1 medications must be prescribed and monitored by a qualified provider; consult your provider to determine whether treatment is appropriate for your individual circumstances. Prices, side-effect rates, and clinical figures shown here are general references drawn from manufacturer labelling and published trials, and may not reflect your specific situation.
Find the right
GLP-1 for you
Compare side by side. No signup required.
What's your
target weight?
Let's find your perfect program
Providers may pay BestGLP1 a referral fee. We disclose this for FTC compliance; rankings remain editorial.